Progressive refractory Light Chain Amyloidosis and Multiple Myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - October 31, 2016 Category: Hematology Authors: Adir Shaulov, Chezi Ganzel, Noam Benyamini, Yossef Barshay, Neta Goldschmidt, David Lavie, Diana Libster, Alex Gural, Batia Avni, Moshe E. Gatt Tags: Research Article Source Type: research